Emitasvir Phosphate

磷酸依米他韦

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEmitasvir Phosphate
Drug Alias Name东卫恩DAG-181
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNonstructural protein 5A inhibitors
TargetsNonstructural protein 5A
Therapy Area/IndicationsRenal InsufficiencyHepatic InsufficiencyHepatitis C, Chronic +[4] 
Global Approved IndicationsHepatitis C
Approved Indications in ChinaHepatitis C
Original Approved Country/TerritoryMainland China
Original Approved Date2020/12/21
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesYichang Hec Changjiang Pharmaceutical Co LtdGuangdong Dongyangguang Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSunshine Lake Pharma Co LtdYichang Hec Changjiang Pharmaceutical Co Ltd
Inactive CompaniesDongguan Hec Taigen Biopharmaceuticals Co LtdGuangdong Dongyangguang Pharmaceutical Co Ltd
Active IndicationsRenal InsufficiencyHepatic InsufficiencyHepatitis C
Inactive IndicationsHepatitis C, Chronic

Other Information

ATC CodeJ05AP
Related LinksN/A